How should levothyroxine be initiated and titrated for hypothyroidism, including dosing based on weight and age, and what target TSH and free T4 values should be aimed for?

Levothyroxine Initiation and Titration for Hypothyroidism

For adults with primary hypothyroidism, start levothyroxine at 1.6 mcg/kg/day as full replacement dosing in most patients, titrate by 12.5-25 mcg every 4-6 weeks until TSH normalizes to 0.5-2.0 mIU/L, with the goal of achieving clinical euthyroidism. 1

Initial Dosing Strategy

Adults Without Cardiac Risk

• Start with full replacement dose of 1.6 mcg/kg/day for most adults diagnosed with hypothyroidism 1
• This weight-based approach allows for more rapid achievement of euthyroidism in younger, healthy patients 1
• Doses greater than 200 mcg/day are seldom required; inadequate response to >300 mcg/day suggests poor compliance, malabsorption, or drug interactions 1

High-Risk Populations Requiring Lower Starting Doses

Elderly patients (≥65 years):

• Start with lower doses than 1.6 mcg/kg/day 1
• Recent evidence shows older adults require only 1.09 mcg/kg actual body weight or 1.35 mcg/kg ideal body weight for euthyroid maintenance—approximately one-third lower than younger populations 2
• 84% of euthyroid elderly individuals are maintained on doses <1.6 mcg/kg 2

Patients with cardiac disease or atrial fibrillation risk:

• Start with lower doses (less than 1.6 mcg/kg/day) 1
• Titrate more slowly every 6-8 weeks (rather than 4-6 weeks) to avoid exacerbation of cardiac symptoms 1
• Even minimal TSH elevations may not require adjustment in patients with arrhythmias who feel well 3

Obese patients:

• Calculate dose using ideal body weight rather than actual body weight 2
• Mean euthyroid dose in obese individuals is 1.42 mcg/kg ideal body weight versus 0.9 mcg/kg actual body weight 2

Titration Protocol

Standard Titration

• Increase by 12.5-25 mcg increments every 4-6 weeks until patient is clinically euthyroid 1
• Peak therapeutic effect of any given dose may not be attained for 4-6 weeks, necessitating this waiting period before dose adjustment 1
• For elderly or cardiac patients, extend titration interval to 6-8 weeks 1

Pediatric Dosing (Weight and Age-Based)

Infants and young children require higher weight-based doses: 1

• 0-3 months: 10-15 mcg/kg/day
• 3-6 months: 8-10 mcg/kg/day
• 6-12 months: 6-8 mcg/kg/day
• 1-5 years: 5-6 mcg/kg/day
• 6-12 years: 4-5 mcg/kg/day

• 12 years (growth incomplete): 2-3 mcg/kg/day

• Growth complete: 1.6 mcg/kg/day

Titrate every 2 weeks in pediatric patients based on TSH or free-T4 1

Target Laboratory Values

Primary Hypothyroidism

Target TSH: 0.5-2.0 mIU/L for optimal symptom control 4

• FDA labeling states to titrate until serum TSH returns to normal 1
• For patients with persistent symptoms despite TSH in upper half of reference range, consider increasing dose to bring TSH to lower portion of reference range 3
• Guidelines acknowledge this strategy is controversial as no data demonstrate improved clinical outcomes, but it is reasonable for symptomatic patients 3

Secondary/Tertiary (Central) Hypothyroidism

TSH is NOT a reliable monitoring parameter 1

• Use free-T4 level to titrate dosing 1
• Target: upper half of normal range for age 1, 4
• Ensure evaluation and treatment of other pituitary hormone deficiencies, especially adrenal insufficiency, before initiating levothyroxine 4

Special Populations

Pregnancy

• Monitor TSH and free-T4 as soon as pregnancy is confirmed and at minimum during each trimester 1
• Levothyroxine requirements frequently increase during pregnancy 3
• Check TSH every 6-8 weeks during pregnancy and adjust dose as needed 3
• Target: trimester-specific TSH reference range 1
• For women planning pregnancy with subclinical hypothyroidism, treat to restore TSH to reference range due to risk of fetal wastage and neuropsychological complications 3

Subclinical Hypothyroidism Treatment Thresholds

TSH >10 mIU/L:

• Levothyroxine therapy is reasonable given 5% annual progression rate to overt hypothyroidism 3
• Treatment may prevent manifestations and consequences of hypothyroidism 3

TSH 5-10 mIU/L:

• Evidence for treatment benefit is inconclusive 3
• Consider treatment in: symptomatic patients, those with positive anti-TPO antibodies, goiter, infertility, or pregnancy 4
• Avoid treatment in patients >85 years with TSH up to 10 mIU/L based on limited evidence 4

Administration Guidelines

Timing and Absorption

• Administer on empty stomach, 30-60 minutes before breakfast with full glass of water 1
• Fasting intake significantly improves absorption compared to administration with food 5
• Wait at least 4 hours before or after drugs that interfere with absorption (iron, calcium, proton pump inhibitors, bile acid sequestrants) 1

Common Pitfalls Leading to Inadequate Response

When TSH remains elevated despite apparently adequate dosing, systematically evaluate: 1, 4

• Poor compliance (most common)
• Malabsorption (celiac disease, atrophic gastritis, inflammatory bowel disease)
• Drug interactions (iron, calcium, PPIs, estrogen, enzyme inducers)
• Taking with food rather than on empty stomach
• Subclinical hypothyroidism progressing to overt disease

Monitoring Schedule

• Initial follow-up: 4-6 weeks after starting therapy or dose change 1
• Once stable: monitor TSH annually in most patients 4
• More frequent monitoring needed in: pregnancy (every 6-8 weeks), elderly patients, those with cardiac disease, or when medications/conditions affecting absorption are present 3, 1

Risks of Over-Replacement

Avoid excessive dosing as even slight over-replacement increases risk of: 4, 6

• Atrial fibrillation (especially in elderly)
• Osteoporotic fractures
• Symptoms of thyrotoxicosis (tachycardia, tremor, sweating)

When TSH is suppressed (<0.1 mIU/L) in levothyroxine-treated patients without thyroid cancer or nodules, decrease the dose to allow TSH to increase toward reference range 3